Is Ayala Pharmaceuticals, Inc. (ADXS) a Buy, Sell, or Hold?
OTC : ADXS
Ayala Pharmaceuticals, Inc. — Insider Trades
$0.60355 USD
$0 (0.0%)
- Volume
- 10.01K
- Average Volume
- 5.05K
- Market Capitalization
- $25.71M
- P/E Ratio
- -0.08
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.80
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.30
Insider Activity Summary (Last 12 Months)
Insiders Buying
18
Insiders Selling
5
Amount of Insider Selling
$53000
ADXS Insider Buying/Selling by Quarter
ADXS Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-03-01 | M-Exempt | 0.4 | 2024-03-06 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-03-01 | M-Exempt | 0.4 | 2024-03-06 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-03-01 | M-Exempt | 0.4 | 2024-03-06 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-03-01 | M-Exempt | 0.4 | 2024-03-06 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-03-01 | M-Exempt | 0.4 | 2024-03-06 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-03-01 | M-Exempt | 0.4 | 2024-03-06 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-02-07 | M-Exempt | 0.4 | 2024-02-12 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-02-07 | F-InKind | 1.2465 | 2024-02-12 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-02-07 | M-Exempt | 0.4 | 2024-02-12 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-02-07 | F-InKind | 1.2465 | 2024-02-12 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-02-07 | M-Exempt | 0.4 | 2024-02-12 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-02-07 | M-Exempt | 0.4 | 2024-02-12 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-02-07 | M-Exempt | 0.4 | 2024-02-12 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-02-07 | M-Exempt | 0.4 | 2024-02-12 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-02-07 | M-Exempt | 0.4 | 2024-02-12 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-02-07 | M-Exempt | 0.4 | 2024-02-12 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-02-07 | M-Exempt | 0.4 | 2024-02-12 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-02-07 | M-Exempt | 0.4 | 2024-02-12 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-02-07 | M-Exempt | 0.4 | 2024-02-12 |
| Israel Biotech Fund I, L.P. | director, 10 percent owner: | 2024-02-07 | M-Exempt | 0.4 | 2024-02-12 |
| Israel Biotech Fund I, L.P. | 10 percent owner | 2023-11-17 | P-Purchase | 0.4 | 2023-11-21 |
| Israel Biotech Fund I, L.P. | 10 percent owner | 2023-11-17 | P-Purchase | 0.4 | 2023-11-21 |
| Israel Biotech Fund I, L.P. | 10 percent owner | 2023-11-17 | P-Purchase | 0.4 | 2023-11-21 |
| Israel Biotech Fund I, L.P. | 10 percent owner | 2023-11-17 | P-Purchase | 0.4 | 2023-11-21 |
| Israel Biotech Fund I, L.P. | 10 percent owner | 2023-11-17 | P-Purchase | 0.4 | 2023-11-21 |
| Israel Biotech Fund I, L.P. | 10 percent owner | 2023-11-17 | P-Purchase | 0.4 | 2023-11-21 |
| Israel Biotech Fund I, L.P. | 10 percent owner | 2023-11-17 | P-Purchase | 0.4 | 2023-11-21 |
| Israel Biotech Fund I, L.P. | 10 percent owner | 2023-11-17 | P-Purchase | 0.4 | 2023-11-21 |
| Israel Biotech Fund I, L.P. | 10 percent owner | 2023-11-17 | P-Purchase | 0.4 | 2023-11-21 |
| Israel Biotech Fund I, L.P. | 10 percent owner | 2023-11-17 | P-Purchase | 0.4 | 2023-11-21 |
| Cabilly Yuval | director | 2023-10-18 | 0 | 2023-11-08 | |
| Cabilly Yuval | director | 2023-10-18 | 0 | 2023-11-08 | |
| Golan Roy | 2023-10-18 | 0 | 2023-11-03 | ||
| Orbach Pini | 2023-10-18 | 0 | 2023-11-03 | ||
| Martell Bridget A | 2023-10-18 | 0 | 2023-11-03 | ||
| Israel Biotech Fund I, L.P. | 10 percent owner | 2023-10-18 | P-Purchase | 0 | 2023-10-31 |
| Israel Biotech Fund I, L.P. | 10 percent owner | 2023-10-18 | P-Purchase | 0 | 2023-10-31 |
| aMoon Growth Fund Limited Partnership | 10 percent owner | 2023-10-18 | J-Other | 0 | 2023-10-23 |
| Israel Biotech Fund I, L.P. | 10 percent owner | 2023-01-19 | 0 | 2023-09-29 | |
| Israel Biotech Fund I, L.P. | 10 percent owner | 2023-09-01 | P-Purchase | 0 | 2023-09-11 |
| Israel Biotech Fund I, L.P. | 10 percent owner | 2023-09-01 | P-Purchase | 0 | 2023-09-11 |
| Israel Biotech Fund I, L.P. | 10 percent owner | 2023-01-19 | 0 | 2023-09-11 | |
| aMoon Growth Fund Limited Partnership | director | 2023-01-19 | 0 | 2023-01-30 | |
| SIDRANSKY DAVID | director | 2023-01-19 | A-Award | 0 | 2023-01-23 |
| SIDRANSKY DAVID | director | 2023-01-19 | A-Award | 0 | 2023-01-23 |
| GOLDBERG MURRAY A | director | 2023-01-19 | A-Award | 0 | 2023-01-23 |
| GOLDBERG MURRAY A | director | 2023-01-19 | A-Award | 0 | 2023-01-23 |
| GOLDBERG MURRAY A | director | 2023-01-19 | A-Award | 0 | 2023-01-23 |
| Bisker-Leib Vered | director | 2023-01-19 | A-Award | 0 | 2023-01-23 |
| Bisker-Leib Vered | director | 2023-01-19 | A-Award | 0 | 2023-01-23 |
| Spiegel Robert J. | director | 2023-01-19 | A-Award | 0 | 2023-01-23 |
| Spiegel Robert J. | director | 2023-01-19 | A-Award | 0 | 2023-01-23 |
| Spiegel Robert J. | director | 2023-01-19 | A-Award | 0 | 2023-01-23 |
| GOLDBERG MURRAY A | None | 2023-01-19 | None | 2023-01-23 | |
| GOLDBERG MURRAY A | director: | 2023-01-19 | 0 | 2023-01-23 | |
| Bisker-Leib Vered | None | 2023-01-19 | None | 2023-01-23 | |
| Bisker-Leib Vered | director: | 2023-01-19 | 0 | 2023-01-23 | |
| Spiegel Robert J. | director: | 2023-01-19 | 0 | 2023-01-23 | |
| Spiegel Robert J. | None | 2023-01-19 | None | 2023-01-23 | |
| Gitelman Igor | officer: Chief Accounting Officer | 2021-02-11 | 0 | 2021-02-16 | |
| Henderson Molly | officer: Executive Vice President & CFO | 2020-05-04 | A-Award | 0.66 | 2020-05-05 |
| Khleif Samir N | director | 2020-05-04 | A-Award | 0.66 | 2020-05-05 |
| APPEL RONI | director | 2020-05-04 | A-Award | 0.66 | 2020-05-05 |
| Berlin Kenneth A | officer: President and CEO | 2020-05-04 | A-Award | 0.66 | 2020-05-05 |
| PATTON JAMES P | director | 2020-05-04 | A-Award | 0.66 | 2020-05-05 |
| SIDRANSKY DAVID | director | 2020-05-04 | A-Award | 0.66 | 2020-05-05 |
| BERMAN RICHARD J | director | 2020-05-04 | A-Award | 0.66 | 2020-05-05 |
| Gutierrez Andres | officer: Executive Vice President & CMO | 2020-05-04 | A-Award | 0.66 | 2020-05-05 |
| APPEL RONI | director | 2020-03-11 | S-Sale | 0.67 | 2020-03-16 |
| APPEL RONI | director | 2020-03-12 | S-Sale | 0.58 | 2020-03-16 |
| APPEL RONI | director | 2020-03-13 | S-Sale | 0.55 | 2020-03-16 |
| Gutierrez Andres | officer: Exec VP, Chief Medical Officer | 2019-10-24 | A-Award | 0.31 | 2019-10-25 |
| BERMAN RICHARD J | director | 2019-10-24 | A-Award | 0.31 | 2019-10-25 |
| SIDRANSKY DAVID | director | 2019-10-24 | A-Award | 0.31 | 2019-10-25 |
| Henderson Molly | officer: Executive Vice President & CFO | 2019-10-24 | A-Award | 0.31 | 2019-10-25 |
| APPEL RONI | director | 2019-10-24 | A-Award | 0.31 | 2019-10-25 |
| Khleif Samir N | director | 2019-10-24 | A-Award | 0.31 | 2019-10-25 |
| Berlin Kenneth A | director, officer: President & CEO | 2019-10-24 | A-Award | 0.31 | 2019-10-25 |
| PATTON JAMES P | director | 2019-10-24 | A-Award | 0.31 | 2019-10-25 |
| Gutierrez Andres | officer: Executive Vice President & CMO | 2019-04-11 | A-Award | 3.7142 | 2019-04-11 |
| APPEL RONI | director | 2019-04-10 | P-Purchase | 3.797 | 2019-04-11 |
| Henderson Molly | officer: Executive Vice President & CFO | 2019-04-11 | A-Award | 3.6799 | 2019-04-11 |
| Henderson Molly | officer: Executive Vice President & CFO | 2019-04-09 | A-Award | 3.8599 | 2019-04-10 |
| Henderson Molly | officer: Executive Vice President & CFO | 2019-04-09 | A-Award | 3.85 | 2019-04-10 |
| Berlin Kenneth A | director, officer: President & CEO | 2019-04-08 | A-Award | 3.779 | 2019-04-08 |
| Berlin Kenneth A | director, officer: President & CEO | 2019-04-08 | A-Award | 3.775 | 2019-04-08 |
| Berlin Kenneth A | director, officer: President & CEO | 2019-04-08 | A-Award | 3.78 | 2019-04-08 |
| SIDRANSKY DAVID | director | 2018-11-05 | A-Award | 0.54 | 2018-11-07 |
| Henderson Molly | officer: Executive Vice President & CFO | 2018-11-05 | A-Award | 0.54 | 2018-11-07 |
| Berlin Kenneth A | director, officer: President & CEO | 2018-11-05 | A-Award | 0.54 | 2018-11-07 |
| APPEL RONI | director | 2018-11-05 | A-Award | 0.54 | 2018-11-07 |
| PATTON JAMES P | director | 2018-11-05 | A-Award | 0.54 | 2018-11-07 |
| Khleif Samir N | director | 2018-11-05 | A-Award | 0.54 | 2018-11-07 |
| PETIT ROBERT | officer: Chief Scientific Officer | 2018-11-05 | S-Sale | 0.58 | 2018-11-07 |
| PETIT ROBERT | officer: Chief Scientific Officer | 2018-11-05 | A-Award | 0.54 | 2018-11-07 |
| Gutierrez Andres | officer: Exec VP, Chief Medical Officer | 2018-11-05 | A-Award | 0.54 | 2018-11-07 |
| BERMAN RICHARD J | director | 2018-11-05 | A-Award | 0.54 | 2018-11-07 |
| PETIT ROBERT | officer: Chief Scientific Officer | 2018-11-02 | S-Sale | 0.56 | 2018-11-05 |
| APPEL RONI | director | 2018-09-11 | P-Purchase | 1.2 | 2018-09-13 |
| APPEL RONI | director | 2018-09-11 | P-Purchase | 1.5 | 2018-09-13 |